These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29244999)

  • 1. Mechanical stress increases brain amyloid β, tau, and α-synuclein concentrations in wild-type mice.
    Levy Nogueira M; Hamraz M; Abolhassani M; Bigan E; Lafitte O; Steyaert JM; Dubois B; Schwartz L
    Alzheimers Dement; 2018 Apr; 14(4):444-453. PubMed ID: 29244999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides.
    Di Scala C; Yahi N; Flores A; Boutemeur S; Kourdougli N; Chahinian H; Fantini J
    Biochim Biophys Acta; 2016 Feb; 1862(2):213-22. PubMed ID: 26655601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous Murine Amyloid-β Peptide Assembles into Aggregates in the Aged C57BL/6J Mouse Suggesting These Animals as a Model to Study Pathogenesis of Amyloid-β Plaque Formation.
    Ahlemeyer B; Halupczok S; Rodenberg-Frank E; Valerius KP; Baumgart-Vogt E
    J Alzheimers Dis; 2018; 61(4):1425-1450. PubMed ID: 29376876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinol (Vitamin A) Increases α-Synuclein, β-Amyloid Peptide, Tau Phosphorylation and RAGE Content in Human SH-SY5Y Neuronal Cell Line.
    Kunzler A; Kolling EA; da Silva JD; Gasparotto J; de Bittencourt Pasquali MA; Moreira JCF; Gelain DP
    Neurochem Res; 2017 Oct; 42(10):2788-2797. PubMed ID: 28497345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkin attenuates wild-type tau modification in the presence of beta-amyloid and alpha-synuclein.
    Moussa CE
    J Mol Neurosci; 2009 Jan; 37(1):25-36. PubMed ID: 18561034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases.
    Hannula MJ; Myöhänen TT; Tenorio-Laranga J; Männistö PT; Garcia-Horsman JA
    Neuroscience; 2013 Jul; 242():140-50. PubMed ID: 23562579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aβ, Tau, and α-Synuclein aggregation and integrated role of PARK2 in the regulation and clearance of toxic peptides.
    Kumar D; Kumar P
    Neuropeptides; 2019 Dec; 78():101971. PubMed ID: 31540705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.
    Colom-Cadena M; Gelpi E; Charif S; Belbin O; Blesa R; Martí MJ; Clarimón J; Lleó A
    J Neuropathol Exp Neurol; 2013 Dec; 72(12):1203-12. PubMed ID: 24226269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein.
    Martinez-Valbuena I; Valenti-Azcarate R; Amat-Villegas I; Marcilla I; Marti-Andres G; Caballero MC; Riverol M; Tuñon MT; Fraser PE; Luquin MR
    Acta Neuropathol Commun; 2021 Apr; 9(1):64. PubMed ID: 33832546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
    Williams SM; Schulz P; Sierks MR
    Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies.
    Ferman TJ; Aoki N; Crook JE; Murray ME; Graff-Radford NR; van Gerpen JA; Uitti RJ; Wszolek ZK; Graff-Radford J; Pedraza O; Kantarci K; Boeve BF; Dickson DW
    Alzheimers Dement; 2018 Mar; 14(3):330-339. PubMed ID: 29100980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal Fluid Biomarkers in Highly Exposed PM2.5 Urbanites: The Risk of Alzheimer's and Parkinson's Diseases in Young Mexico City Residents.
    Calderón-Garcidueñas L; Avila-Ramírez J; Calderón-Garcidueñas A; González-Heredia T; Acuña-Ayala H; Chao CK; Thompson C; Ruiz-Ramos R; Cortés-González V; Martínez-Martínez L; García-Pérez MA; Reis J; Mukherjee PS; Torres-Jardón R; Lachmann I
    J Alzheimers Dis; 2016 Sep; 54(2):597-613. PubMed ID: 27567860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias.
    Parnetti L; Chiasserini D; Bellomo G; Giannandrea D; De Carlo C; Qureshi MM; Ardah MT; Varghese S; Bonanni L; Borroni B; Tambasco N; Eusebi P; Rossi A; Onofrj M; Padovani A; Calabresi P; El-Agnaf O
    Mov Disord; 2011 Jul; 26(8):1428-35. PubMed ID: 21469206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegenerative Disease-Related Proteins within the Epidermal Layer of the Human Skin.
    Akerman SC; Hossain S; Shobo A; Zhong Y; Jourdain R; Hancock MA; George K; Breton L; Multhaup G
    J Alzheimers Dis; 2019; 69(2):463-478. PubMed ID: 31006686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of physical exercise on β-amyloid, α-synuclein and tau accumulation: an in vitro model of oxidative stress in human red blood cells.
    Iofrida C; Daniele S; Pietrobono D; Fusi J; Galetta F; Trincavelli ML; Bonuccelli U; Franzoni F; Martini C
    Arch Ital Biol; 2017 Jul; 155(1-2):33-42. PubMed ID: 28715596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau deletion impairs intracellular β-amyloid-42 clearance and leads to more extracellular plaque deposition in gene transfer models.
    Lonskaya I; Hebron M; Chen W; Schachter J; Moussa C
    Mol Neurodegener; 2014 Nov; 9():46. PubMed ID: 25384392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference of α-Synuclein Uptake by Monomeric β-Amyloid1-40 and Potential Core Acting Site of the Interference.
    Chan DK; Braidy N; Xu YH; Chataway T; Guo F; Guillemin GJ; Teo C; Gai WP
    Neurotox Res; 2016 Oct; 30(3):479-85. PubMed ID: 27364697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Tau, β Amyloid and α-Synuclein Pathologies.
    Walker L; Attems J
    Adv Exp Med Biol; 2019; 1184():169-176. PubMed ID: 32096037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncoupling neuronal death and dysfunction in Drosophila models of neurodegenerative disease.
    Chouhan AK; Guo C; Hsieh YC; Ye H; Senturk M; Zuo Z; Li Y; Chatterjee S; Botas J; Jackson GR; Bellen HJ; Shulman JM
    Acta Neuropathol Commun; 2016 Jun; 4(1):62. PubMed ID: 27338814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.